---

A Review article of pharmacovigilance and studies of clinical research for health care

Full Text PDF

---

Review Article

Author Details : Anuja Bharati*, Teena Dubey, Ruchi Thakur, Kadambari Bhosale, Prashant Bhoir, Prashant Bhoir

Volume : 9, Issue : 2, Year : 2024

Article Page : 116-124

https://doi.org/10.18231/j.ijcaap.2024.017

Suggest article by email

Get Permission

Abstract

Pharmacovigilance, the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug- related problems, is intrinsically linked to effective information management. The pivotal role of information in pharmacovigilance encompassing data collection, analysis, and dissemination for optimal patient safety. The foundation of pharmacovigilance lies in robust information system that facilitate the collection of adverse event reports from healthcare professionals, patients, and other stakeholder. The evolution of data sources, emphasizing the integration of electronic health records, wearable devices and real world evidence to enhance the depth and breadth of information available for analysis. Innovative technologies, including artificial intelligence and machine learning, are transforming pharmacovigilance by automating signal detection and predictive modeling. How those tools are utilized to sift through vast datasets, identifying potential safety concerns and aiding regulatory decision-making. Furthermore, the abstract delves into the importance of structured information sharing between regulatory agencies, pharmaceutical companies, healthcare providers. Timely transparent communication of safety information ensure a proactive response to emerging risk and enable the development of effective risk management strategies.The continues evaluation of information management strategies to adapt to the complexities of modern healthcare and pharmaceutical innovation. In essence, this abstract illuminates the symbiotic relationship between pharmacovigilance and information management, showcasing how the effective utilization of diverse and high quality data is fundamental to advancing drug safety practices and safeguarding public health.

Keywords: Clinical trials, Drug safety and efficacy, Drug monitoring, Pharmacovigilance, CDSCO, NDA

How to cite : Bharati A, Dubey T, Thakur R, Bhosale K, Bhoir P, Bhoir P, A Review article of pharmacovigilance and studies of clinical research for health care. IP Int J Compr Adv Pharmacol 2024;9(2):116-124

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.